Antibiotics and Bacterial Resistance in the 21st Century

Антибиотики и бактериальная резистентность в XXI веке
Richard J. Fair, Yitzhak Tor
2014-01-01

antibacterial agentsantibiotic classesantibiotic developmentantibiotic resistancedrug-resistant bacteria
Dangerous, antibiotic resistant bacteria have been observed with increasing frequency over the past several decades. In this review the factors that have been linked to this phenomenon are addressed. Profiles of bacterial species that are deemed to be particularly concerning at the present time are illustrated. Factors including economic impact, intrinsic and acquired drug resistance, morbidity and mortality rates, and means of infection are taken into account. Synchronously with the waxing of bacterial resistance there has been waning antibiotic development. The approaches that scientists are employing in the pursuit of new antibacterial agents are briefly described. The standings of established antibiotic classes as well as potentially emerging classes are assessed with an emphasis on molecules that have been clinically approved or are in advanced stages of development. Historical perspectives, mechanisms of action and resistance, spectrum of activity, and preeminent members of each class are discussed.
1
Antibiotic development has declined while bacterial resistance has increased, creating a widening mismatch between clinical need and therapeutic innovation.
2
Antibiotic-resistant bacteria have increased in frequency over recent decades, driven by multiple linked factors reviewed in the article.
3
The article evaluates established and emerging antibiotic classes, emphasizing clinically approved agents and compounds in advanced development.
4
The review profiles currently concerning bacterial species using economic impact, intrinsic and acquired resistance, morbidity, mortality, and transmission routes.
5
The review summarizes antibacterial discovery approaches alongside historical perspectives, mechanisms of action and resistance, activity spectra, and representative drugs.

Antibiotic drugs and clinically significant antibiotic-resistant bacteria

Factors driving bacterial resistance, the clinical and epidemiological impact of resistant bacteria, mechanisms of antibiotic action and resistance, and the development status of antibacterial agents

Publication Details
Publication Date
2014-01-01
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Richard J. Fair
Yitzhak Tor
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%